Status:
RECRUITING
Reduction of Blood Recirculation in Veno-Venous ECMO
Lead Sponsor:
Charite University, Berlin, Germany
Conditions:
Extracorporeal Membrane Oxygenation
Acute Respiratory Distress Syndrome
Eligibility:
All Genders
18+ years
Brief Summary
Blood which recirculates through the circuit of a veno-venous Extracorporeal Membrane Oxygenation (V-V ECMO) does not contribute to the systemic oxygenation of a patient on V-V ECMO and is called the ...
Detailed Description
Based on data from the 'Blood Recirculation and vvECMO' trial (ClinicalTrials.gov ID: NCT03200314) (i.e. an expected frequency of successful blood flow reduction of 66.7%), using a one-sample Chi squa...
Eligibility Criteria
Inclusion
- Patients aged 18 years or older requiring veno-venous ECMO for treatment of refractory hypoxemia in ARDS.
Exclusion
Key Trial Info
Start Date :
November 20 2020
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
October 31 2026
Estimated Enrollment :
136 Patients enrolled
Trial Details
Trial ID
NCT04754854
Start Date
November 20 2020
End Date
October 31 2026
Last Update
December 31 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Charité - Universitätsmedizin Berlin, Campus Virchow Klinikum
Berlin, Germany, 13353